CREYON Trademark

Trademark Overview

On Friday, July 23, 2021, a trademark application was filed for CREYON with the United States Patent and Trademark Office. The USPTO has given the CREYON trademark a serial number of 90846010. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Friday, March 14, 2025. This trademark is owned by Creyon Bio, Inc.. The CREYON trademark is filed in the Pharmaceutical Products category with the following description:

Diagnostic preparations and therapeutics for medical use, namely, oligonucleotides; drug delivery agents consisting of compounds that facilitate delivery of a wide range of Oligonucleotide-Based Medicines; pharmaceutical preparations of Oligonucleotide-Based Medicines for gene therapy, cell therapy, personalized medicine, and precision medicine; pharmaceutical preparations of Oligonucleotide-Based Medicines for use in the treatment of genetically based diseases and rare diseases; pharmaceutical preparations of oligonucleotide therapeutics for use in the treatment of genetically based diseases, multigenic diseases, rare diseases and ultra-rare diseases
creyon

General Information

Serial Number90846010
Word MarkCREYON
Filing DateFriday, July 23, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateFriday, March 14, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 24, 2023

Trademark Statements

Goods and ServicesDiagnostic preparations and therapeutics for medical use, namely, oligonucleotides; drug delivery agents consisting of compounds that facilitate delivery of a wide range of Oligonucleotide-Based Medicines; pharmaceutical preparations of Oligonucleotide-Based Medicines for gene therapy, cell therapy, personalized medicine, and precision medicine; pharmaceutical preparations of Oligonucleotide-Based Medicines for use in the treatment of genetically based diseases and rare diseases; pharmaceutical preparations of oligonucleotide therapeutics for use in the treatment of genetically based diseases, multigenic diseases, rare diseases and ultra-rare diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, September 23, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCreyon Bio, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NameCreyon Bio, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events

Event DateEvent Description
Thursday, May 12, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, July 27, 2021NEW APPLICATION ENTERED
Thursday, September 23, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, April 18, 2022ASSIGNED TO EXAMINER
Thursday, May 12, 2022NON-FINAL ACTION WRITTEN
Thursday, May 12, 2022NON-FINAL ACTION E-MAILED
Friday, November 11, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, November 11, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, November 11, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, December 19, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 4, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 21, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, September 15, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, January 24, 2023PUBLISHED FOR OPPOSITION
Tuesday, January 24, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Friday, September 15, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, September 20, 2023SOU TEAS EXTENSION RECEIVED
Friday, September 15, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, September 20, 2023SOU EXTENSION 1 FILED
Wednesday, September 20, 2023SOU EXTENSION 1 GRANTED
Monday, March 11, 2024SOU TEAS EXTENSION RECEIVED
Friday, September 6, 2024SOU TEAS EXTENSION RECEIVED
Friday, September 22, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 11, 2024SOU EXTENSION 2 FILED
Monday, March 11, 2024SOU EXTENSION 2 GRANTED
Tuesday, March 12, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 6, 2024SOU EXTENSION 3 GRANTED
Friday, September 6, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 14, 2025SOU EXTENSION 4 FILED
Friday, March 14, 2025SOU EXTENSION 4 GRANTED
Saturday, March 15, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 18, 2025SOU TEAS EXTENSION RECEIVED
Friday, March 14, 2025SOU TEAS EXTENSION RECEIVED
Friday, September 6, 2024SOU EXTENSION 3 FILED

Related Keywords

creyon diseases based oligonucleotide preparations rare pharmaceutical medicines therapeutics medicine delivery